{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T05:49:06Z","timestamp":1768888146924,"version":"3.49.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T00:00:00Z","timestamp":1365465600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0060709","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T21:08:19Z","timestamp":1365541699000},"page":"e60709","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["mTOR Inhibition Elicits a Dramatic Response in PI3K-Dependent Colon Cancers"],"prefix":"10.1371","volume":"8","author":[{"given":"Dustin A.","family":"Deming","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa A.","family":"Leystra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Farhoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Nettekoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Clipson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Kay","family":"Washington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamey P.","family":"Weichert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Halberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,4,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1056\/NEJMra0804588","article-title":"Molecular basis of colorectal cancer","volume":"361","author":"SD Markowitz","year":"2009","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1200\/JCO.2009.21.9170","article-title":"American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients with Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy","volume":"27","author":"CJ Allegra","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11523-010-0138-5","article-title":"Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer","volume":"5","author":"A Sartore-Bianchi","year":"2010","journal-title":"Targ Oncol"},{"key":"ref4","unstructured":"American Cancer Society (2011) Cancer Facts &amp; Figures 2011. Atlanta: American Cancer Society."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4161\/cc.8.9.8255","article-title":"PIK3CA mutationsin human solid tumors. Role in sensitivity to various therapeutic approaches","volume":"8","author":"G Ligresti","year":"2009","journal-title":"Cell Cycle"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","article-title":"High frequency of mutations of the PIK3CA gene in human cancers","volume":"304","author":"Y Samuels","year":"2004","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4161\/cc.9.3.10599","article-title":"Hot-spot mutations in p100\u03b1 of phosphatidylinositol 3-kinase (PI3K). Differential interactions with the regulatory subunit p85 and with RAS","volume":"9","author":"L Zhao","year":"2010","journal-title":"Cell Cycle"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-kinase AKT pathway in human cancer","volume":"2","author":"I Vivanco","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1158\/0008-5472.CAN-11-4097","article-title":"Mice expressing activated PI3K rapidly develop advanced colon cancer","volume":"72","author":"A Leystra","year":"2012","journal-title":"Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"38071","DOI":"10.1074\/jbc.274.53.38071","article-title":"Inducible gene knockouts in the small intestinal and colonic epithelium","volume":"274","author":"JR Saam","year":"1999","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cell.2009.08.041","article-title":"PI3 kinase signals BCR-dependent mature B cell survival","volume":"139","author":"L Srinivasan","year":"2009","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.acra.2007.10.005","article-title":"Reproducibility of tumor volume measurement at microCT colonography in living mice","volume":"15","author":"BY Durkee","year":"2008","journal-title":"Acad Radiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/nm.1890","article-title":"Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers","volume":"14","author":"JA Engelman","year":"2008","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/1940-6207.CAPR-10-0228","article-title":"Rapamycin inhibits anal carcinogenesis in two preclinical animal models","volume":"3","author":"MK Stelzer","year":"2010","journal-title":"Cancer Prev Res"},{"key":"ref15","first-page":"3065","article-title":"Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer","volume":"118","author":"A Carracedo","year":"2008","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"KT Flaherty","year":"2010","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1158\/1535-7163.MCT-10-0239","article-title":"Targeted therapies for non-small cell lung cancer: An evolving landscape","volume":"9","author":"SK Pal","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"EL Kwak","year":"2011","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJMp1100548","article-title":"Early accelerated approval for highly targeted cancer drugs","volume":"364","author":"BA Chabner","year":"2011","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1200\/JCO.2011.36.1196","article-title":"PI3K\/AKT\/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations","volume":"30","author":"F Janku","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1593\/neo.08336","article-title":"<italic>PIK3CA<\/italic> mutation in colorectal cancer: Relationship with genetic and epigenetic alterations","volume":"10","author":"K Nosho","year":"2008","journal-title":"Neoplasia"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM198809013190901","article-title":"Genetic alterations during colorectal-tumor development","volume":"319","author":"B Vogelstein","year":"1988","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/0092-8674(92)90643-Q","article-title":"Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases","volume":"69","author":"J Chung","year":"1992","journal-title":"Cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1242\/jcs.02950","article-title":"RSK and MSK in MAP kinases signaling","volume":"119","author":"C Hauge","year":"2006","journal-title":"J Cell Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/MCB.24.8.3112-3124.2004","article-title":"S6K1(\u2212\/\u2212)\/S6K2(\u2212\/\u2212) mice exhibit perinatal lethality and rapamycin-sensitive 5\u2032-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinae pathway","volume":"24","author":"M Pende","year":"2004","journal-title":"Mol Cell Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"14056","DOI":"10.1074\/jbc.M700906200","article-title":"RAS\/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation","volume":"282","author":"PP Roux","year":"2007","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/bjc.2012.70","article-title":"The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition","volume":"106","author":"EJ Haagensen","year":"2012","journal-title":"Br J Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1158\/1078-0432.CCR-11-2683","article-title":"Inhibition of MEK and PI3K\/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas","volume":"18","author":"G Migliardi","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1158\/1078-0432.CCR-11-2381","article-title":"The clinical effect of the dual-targeting strategy involving PI3K\/AKT\/mTOR and RAS\/MEK\/ERK pathways in patients with advanced cancer","volume":"18","author":"T Shimizu","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1634\/theoncologist.2010-0402","article-title":"Targeting the phosphatidylinositol 3-kinase signaling pathway in breast cancer","volume":"16","author":"LF Hernandez-Aya","year":"2011","journal-title":"Oncologist"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.18632\/oncotarget.166","article-title":"PI3K\u03b1 inhibitors that inhibit metastases","volume":"1","author":"O Schmidt-Kittler","year":"2010","journal-title":"Oncotarget"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.gde.2009.11.002","article-title":"Targeting the PI3K signaling pathway in cancer","volume":"20","author":"KK Wong","year":"2010","journal-title":"Curr Opin Genet Dev"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Juric D, Rodon J, Gonzalez-Angulo AM, Burris HA, Bendell J, <etal>et al<\/etal>.. (2012) Abstract CT-01: BYL719, a next generation PI3K alpha specific inhibitor: Preliminary safety, PK, and efficacy results from the first-in-human study. Cancer Res 72: Supplement 1.","DOI":"10.1158\/1538-7445.AM2012-CT-01"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0060709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T04:16:05Z","timestamp":1595650565000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0060709"}},"subtitle":[],"editor":[{"given":"Rakesh K.","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,9]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0060709","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,9]]}}}